Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000250
Chunk: 118

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 118
---
 option of the holder after a qualified offering. If no qualified offering
occurs prior to the maturity date, the March 2024 Note is to be repaid in cash.

On January 11, 2024, the Company
entered into a Subscription Agreement with an investor to issue a Convertible Promissory Note (the “January 2024 Note I”)
in the amount of $460,000. The January 2024 Note I bears an interest rate of 12% per annum and shall mature on January 11, 2025. The Company
is required to pay interest quarterly, in arrears, in cash, on the first day of each quarter of each year following the Issue Date prior
to the maturity of the Notes. Notwithstanding the immediately foregoing, at the option of the Holder, interest may accrue on this Note
on a quarterly basis. The January 2024 Note I is convertible either at the option of the Holder or automatically upon maturity into shares
of the Company’s Common Stock at the conversion price of $3.38.

On January 12, 2024, the Company
entered into a Subscription Agreement with an investor (the “Investor”) to issue a Convertible Promissory Note for an aggregate
principal amount of $125,000 (the “January 2024 Note II”, and collectively with the January 2024 Note I, the “January
2024 Notes”). The Company received a total of $125,000 in gross proceeds. The January 2024 Note II bears an interest rate of
12% per annum and shall mature on December 29, 2024 (the “Maturity Date”). The Company is required to pay interest quarterly,
in arrears, in cash, on the first day of each quarter of each year following the issue date prior to the maturity of the 2024 Notes. The
January 2024 Note II is convertible either at the option of the Holder or automatically upon maturity into shares of the Company’s
Common Stock at the Note Conversion Price of $3.38.

<div align='center'>63</div>

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Insider Trading Plans

During the quarter ended March 31, 2024, no director
or Section 16 officer adopted, modified, or terminated any “Rule 10b5-1 trading arrangement” or “non